Clinical Trial Update: Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sorafenib for patients with metastatic renal cell carcinoma that has spread to the brain. The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED